-+ 0.00%
-+ 0.00%
-+ 0.00%

Intelligent Bio Solutions advances FDA 510(k) submission after penetration test finds no major flaws

PUBT·04/17/2026 12:34:27
Listen to the news
Intelligent Bio Solutions advances FDA 510(k) submission after penetration test finds no major flaws
  • Intelligent Bio Solutions completed penetration testing tied to its upcoming FDA 510(k) submission, with no major vulnerabilities identified.
  • Security upgrades were implemented to support the filing, including encrypted identification tags and tighter firmware controls.
  • FDA clearance, if obtained, would expand access to US drug screening market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on April 17, 2026, and is solely responsible for the information contained therein.